Addus HomeCare price target lowered to $109 from $123 at RBC Capital

RBC Capital analyst Ben Hendrix lowered the firm’s price target on Addus HomeCare to $109 from $123 and keeps an Outperform rating on the shares after its "solid" Q1 results. The price target cut captures the regulatory backdrop and management’s decision to pause M&A until the industry gains more clarity on CMS proposals, but shares also look oversold at current levels, the analyst tells investors in a research note.